Penserra Capital Management LLC grew its position in abrdn Healthcare Investors (NYSE:HQH - Free Report) by 8.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,008,526 shares of the financial services provider's stock after acquiring an additional 78,771 shares during the period. Penserra Capital Management LLC owned about 1.87% of abrdn Healthcare Investors worth $16,378,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. grew its position in shares of abrdn Healthcare Investors by 18.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 83,775 shares of the financial services provider's stock valued at $1,361,000 after acquiring an additional 13,147 shares during the period. Janney Montgomery Scott LLC grew its position in shares of abrdn Healthcare Investors by 2.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 155,593 shares of the financial services provider's stock valued at $2,527,000 after acquiring an additional 3,144 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of abrdn Healthcare Investors during the 1st quarter worth about $189,000. RFG Advisory LLC bought a new stake in shares of abrdn Healthcare Investors during the 1st quarter worth about $213,000. Finally, Milestone Asset Management LLC boosted its holdings in shares of abrdn Healthcare Investors by 30.5% during the 1st quarter. Milestone Asset Management LLC now owns 13,746 shares of the financial services provider's stock worth $223,000 after buying an additional 3,215 shares during the period. Institutional investors own 32.60% of the company's stock.
abrdn Healthcare Investors Stock Performance
Shares of HQH stock traded up $0.22 during midday trading on Wednesday, hitting $15.96. 292,091 shares of the company were exchanged, compared to its average volume of 198,773. The firm's 50 day moving average price is $15.59 and its two-hundred day moving average price is $16.27. abrdn Healthcare Investors has a 52 week low of $13.77 and a 52 week high of $19.79.
abrdn Healthcare Investors Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Thursday, May 22nd were issued a dividend of $0.54 per share. This is an increase from abrdn Healthcare Investors's previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Thursday, May 22nd. This represents a $2.16 annualized dividend and a dividend yield of 13.53%.
abrdn Healthcare Investors Profile
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
See Also
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
